Charles Russell Speechlys advises Kreos Capital and Silicon Valley Bank on £20 million growth capital investment in Mereo BioPharma
Charles Russell Speechlys have advised Kreos Capital and Silicon Valley Bank on a £20 million growth capital investment in Mereo BioPharma, a UK-based specialty bio-pharmaceutical company listed on the AIM market of the London Stock Exchange.
Mereo BioPharma was established to address the R&D and financial challenges faced by an increasing number of large pharmaceutical and biotech companies, and to optimise drug development and ensure that promising drug candidates fulfil their potential.
Mereo BioPharma announced to the market that it will use the financing to increase its operational and development flexibility.
The Charles Russell Speechlys core team comprised Chris Putt (Partner), Rossana Conti (Senior Associate), Amelly Kok (Associate) and Olivia Mackie (Associate) from our Corporate Team, and Daniel Sullivan (Partner) and Susan Mitchell (Senior Associate) from our Banking Team.”
Our thinking
Lynsey Inglis
Part 2: The Tip of the Triangle – Taking advantage of London’s potential in the Life Sciences Sector
Rebecca Burford
Charles Russell Speechlys advises Guildford Games Developer Community on the launch of Guildford.Games Ltd
Charles Russell Speechlys has advised the Guildford.Games committee, a not-for-profit initiative, on the formation of Guildford.Games Ltd
Emily Sutton
Mandatory climate-related financial disclosures requirements for companies and LLPs
Internationally, companies are becoming increasingly aware of the risk that climate change poses to their business prospects.
Amy Shuttleworth
Part 1: The Tip of the Triangle – Examining London’s Potential in the Life Sciences Sector
Fiona Edmond
Construction and the Multimodal Approach in the Life Sciences Industry
David Coates
Charles Russell Speechlys advises shareholders on the sale of Rosebourne Limited to Hillier Nurseries
Charles Russell Speechlys advises shareholders on the sale of Rosebourne Limited to Hillier Nurseries
Adrian Mayer
Charles Russell Speechlys wins Best Legal Services: Private Equity – Pan – Africa at the AGF Service Providers Awards 2022
Best Legal Services: Private Equity – Pan – Africa at the AGF Service Providers Awards 2022
Caroline Young
AI and Big Data continue to shape the future of life sciences, but what challenges do we face?
Stephen Burns
Appointing a Director
This article explores some of the ways that additional directors can be appointed.
Adrian Mayer
Charles Russell Speechlys wins Deals Legal Advisor of the Year at the Private Equity Africa Awards 2022
Charles Russell Speechlys wins Deals Legal Advisor of the Year at the Private Equity Africa Awards 2022
Ghassan El Daye
Business Crime Law and Regulations UAE 2023
Ghassan El Daye authors the UAE chapter of the ICLG, Business Crime 2023.
Adrian Mayer
Charles Russell Speechlys advises Daystar Power Group Limited on its acquisition by Shell
Charles Russell Speechlys advises Daystar Power Group Limited on its acquisition by Shell
Manoj Vaghela
Charles Russell Speechlys succeed in Greggs v Zurich Covid-19 insurance trial
Charles Russell Speechlys successfully act for Greggs in landmark business interruption trial
Olivier Cavadini
Federal Council initiates process for drafting of bill on central beneficial owners registry
Find out why the Federal Council have instructed the Federal Department of Finance to draft a bill on a central beneficial owners registry
Adrian Mayer
Charles Russell Speechlys advises AgDevCo on its multi-million investment into Flow Equity
Charles Russell Speechlys has advised longstanding client AgDevCo on its recent participation in a $14 million funding round in Flow Equity
Sarah Wigington
Charles Russell Speechlys advises Housebuilder Countryside in its partnership with Redbridge council to build up to 1,000 homes in east London centre
Charles Russell Speechlys has acted for Countryside for over 35 years.
Darren Bailey
Private Equity News quotes Darren Bailey on US investment in European football
“Relegation, or a failure to qualify for European competition, can have catastrophic financial implications for clubs in Europe."
Roger Elford
Roger Elford writes for EG on the UK restructuring regime
Is the UK restructuring regime fit for purpose?
Mark Howard
Charles Russell Speechlys advises REaD Group on company sale to Sagacity Solutions
Charles Russell Speechlys advises REaD Group on company sale to Sagacity Solutions
Cara Imbrailo
A partnership for progress
The rise of joint ventures in the UK’s life sciences sector.